Prevalence of Immunological Defects in a Cohort of 97 Rubinstein–Taybi Syndrome Patients

Autor: Manuela Cortesi, Elisabetta Prada, Davide Montin, Fabio Cardinale, Alessia Morreale, Silvia Ricci, Antonio Marzollo, Mathilde Nizon, Igor Romaniouk, Donatella Milani, Richard Herriot, Raffaele Badolato, Francesco Saettini, Cristina Gervasini, Daniele Zama, Marie Vincent, Andrea Biondi, Vassilios Lougaris, Elena Domínguez-Garrido, Rika Kosaki
Přispěvatelé: Saettini, F, Herriot, R, Prada, E, Nizon, M, Zama, D, Marzollo, A, Romaniouk, I, Lougaris, V, Cortesi, M, Morreale, A, Kosaki, R, Cardinale, F, Ricci, S, Dominguez-Garrido, E, Montin, D, Vincent, M, Milani, D, Biondi, A, Gervasini, C, Badolato, R, Saettini F., Herriot R., Prada E., Nizon M., Zama D., Marzollo A., Romaniouk I., Lougaris V., Cortesi M., Morreale A., Kosaki R., Cardinale F., Ricci S., Dominguez-Garrido E., Montin D., Vincent M., Milani D., Biondi A., Gervasini C., Badolato R.
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Male
Pediatrics
lymphoproliferation
T-Lymphocytes
Autoimmunity
medicine.disease_cause
Cohort Studies
Hypogammaglobulinemia
Medical microbiology
Prevalence
Immunology and Allergy
Child
Immunodeficiency
Rubinstein-Taybi Syndrome
EP300
B cell
B-Lymphocytes
humoral defects
Incidence
B-Lymphocyte
humoral defect
Middle Aged
CREBBP
syndromic immunodeficiency
Immunoglobulin Isotypes
Phenotype
Immune System Diseases
Child
Preschool

Cohort
Female
Disease Susceptibility
Human
Cohort study
Adult
medicine.medical_specialty
Rubinstein–Taybi syndrome
Adolescent
Immune System Disease
hypogammaglobulinemia
Immunology
Genetic Association Studie
Young Adult
antibody deficiency
B cells
medicine
Humans
Genetic Association Studies
antibody deficiency
B cells
CREBBP
EP300
humoral defects
lymphoproliferation
Rubinstein–Taybi syndrome
syndromic immunodeficiency

business.industry
Infant
Biomarker
Immune dysregulation
medicine.disease
Immunoglobulin Isotype
T-Lymphocyte
Mutation
Primary immunodeficiency
Cohort Studie
business
Biomarkers
Popis: Although recurrent infections in Rubinstein–Taybi syndrome (RSTS) are common, and probably multifactorial, immunological abnormalities have not been extensively described with only isolated cases or small case series of immune deficiency and dysregulation having been reported. The objective of this study was to investigate primary immunodeficiency (PID) and immune dysregulation in an international cohort of patients with RSTS. All published cases of RSTS were identified. The corresponding authors and researchers involved in the diagnosis of inborn errors of immunity or genetic syndromes were contacted to obtain up-to-date clinical and immunological information. Ninety-seven RSTS patients were identified. For 45 patients, we retrieved data from the published reports while for 52 patients, a clinical update was provided. Recurrent or severe infections, autoimmune/autoinflammatory complications, and lymphoproliferation were observed in 72.1%, 12.3%, and 8.2% of patients. Syndromic immunodeficiency was diagnosed in 46.4% of individuals. Despite the broad heterogeneity of immunodeficiency disorders, antibody defects were observed in 11.3% of subjects. In particular, these patients presented hypogammaglobulinemia associated with low B cell counts and reduction of switched memory B cell numbers. Immunoglobulin replacement therapy, antibiotic prophylaxis, and immunosuppressive treatment were employed in 16.4%, 8.2%, and 9.8% of patients, respectively. Manifestations of immune dysfunctions, affecting mostly B cells, are more common than previously recognized in patients with RSTS. Full immunological assessment is warranted in these patients, who may require detailed investigation and specific supportive treatment. [Figure not available: see fulltext.]
Databáze: OpenAIRE